Abstract-Elevated plasma fibrinogen is implicated in cardiovascular disease. However, it is not clear whether fibrinogen levels predict the development of hypertension. We examined the relationship between plasma fibrinogen level and hypertension in a population-based cohort study of 3654 participants (mean age: 61.5 years; range: 49 to 84 years) at the baseline examination (1992)(1993)(1994) in the Blue Mountains region, west of Sydney, Australia, who were examined 5 years (1997)(1998)(1999) later. Main outcomes of interest were prevalent hypertension (systolic blood pressure Ն140 mm Hg, diastolic blood pressure Ն90 mm Hg, or a combination of self-reported hypertension diagnosis and use of antihypertensive medications) at baseline (nϭ2212/3180) and 5-year incidence of hypertension among baseline normotensive individuals (nϭ361/637). Elevated plasma fibrinogen level was positively associated with prevalent hypertension both among men and women and positively associated with 5-year incident hypertension among men, independent of several cardiovascular risk factors. Multivariable odds ratio (95% CI) of 5-year incident hypertension comparing tertile 3 of plasma fibrinogen (Ն3.9 g/L) with tertile 1 (Յ3.2 g/L) was 1.95 (1.03 to 3.68; P trendϭ0.040). This prospective association, however, was not observed in women (odds ratio; 95% CI) comparing tertile 3 versus tertile 1 of plasma fibrinogen (1.00; 0.54 to 1.86; P trendϭ0.986). Subgroup analyses stratified by smoking, body mass index, diabetes, and blood pressure categories supported this male gender-specific pattern of association. These data provide prospective epidemiological evidence of an essential link between plasma fibrinogen level and incident hypertension among men but not among women, a finding consistent with that observed in the Atherosclerosis Risk in Communities Study. A cross several studies, plasma fibrinogen is a consistent predictor of cardiovascular disease, 1-3 subclinical atherosclerosis, 4 -6 peripheral vascular disease, 7 and decreased survival. 3 Several 8 -17 but not all 18 -23 previous cross-sectional epidemiological studies reported a positive association between plasma fibrinogen level and elevated blood pressure and/or prevalent hypertension. In contrast, the only prospective study available on this topic by Folsom et al 24 reported that plasma fibrinogen level predicted 6-year incident hypertension among middle-aged men only, but not women, in the biracial Atherosclerosis Risk In Communities (ARIC) Study. The prospective association between plasma fibrinogen level and incident hypertension is still not clear, particularly by gender. In this report, we examined the association between plasma fibrinogen level and 5-year incident hypertension among men and women in an older Australian population, after adjusting for smoking, alcohol intake, body mass index (BMI), and other cardiovascular risk factors.
A cross several studies, plasma fibrinogen is a consistent predictor of cardiovascular disease, 1-3 subclinical atherosclerosis, 4 -6 peripheral vascular disease, 7 and decreased survival. 3 Several 8 -17 but not all 18 -23 previous cross-sectional epidemiological studies reported a positive association between plasma fibrinogen level and elevated blood pressure and/or prevalent hypertension. In contrast, the only prospective study available on this topic by Folsom et al 24 reported that plasma fibrinogen level predicted 6-year incident hypertension among middle-aged men only, but not women, in the biracial Atherosclerosis Risk In Communities (ARIC) Study. The prospective association between plasma fibrinogen level and incident hypertension is still not clear, particularly by gender. In this report, we examined the association between plasma fibrinogen level and 5-year incident hypertension among men and women in an older Australian population, after adjusting for smoking, alcohol intake, body mass index (BMI), and other cardiovascular risk factors.
Methods
The Blue Mountains Eye Study (BMES) is a population-based cohort study of age-related eye diseases and other health outcomes in an older urban Australian population. 25 After a door-to-door census of residents living in 2 postcodes in the Blue Mountains region, west of Sydney, persons born before January 1, 1943, were invited to attend a detailed examination at a local hospital. Baseline examination was performed on 3654 of 4433 (82.4%) eligible persons during 1992-1994. 26 During the 5-year follow-up examination (1997) (1998) (1999) , 2335 (75.1%) surviving participants were re-examined. This study followed the recommendations of the Declaration of Helsinki, was approved by the Western Sydney Area Health Services Human Research Ethics Committee, and written informed consent was obtained from all of the participants.
Exposure Measurement
The baseline examination and 5-year follow-up examination followed similar protocols and included measuring weight, height, and systolic and diastolic blood pressures (BP) by a trained interviewer and administering a standardized questionnaire collecting information regarding demographic characteristics, cigarette smoking, alcohol intake, physical activity, and medical histories.
Fasting blood specimens were drawn from 3222 participants (88%), centrifuged onsite, and then couriered within the same day to Westmead Hospital, Sydney, for hematology and clinical biochemistry assessment. Plasma fibrinogen was determined using the prothrombin time-derived technique on an ACL 300R coagulometer. White blood cell count was determined using a Coulter counter method. Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TGs) were measured on a Reflotron reflectance photometric analyzer (Boehringer Mannheim Diagnostics [currently Roche Diagnostics]). Fasting plasma glucose was measured by hexokinase method.
Age was defined as age at the baseline examination; education was categorized into beyond high school, high school, and below high school; BMI was calculated as weight (kilograms) divided by height (meters 2 ); diabetes status was categorized using American Diabetes Association criteria, as follows: diabetes (diagnosis of diabetes by a physician and use of diabetic medications or fasting glucose levels Ն7.0 mmol/L [126 mg/dL]), fasting hyperglycemia (fasting glucose levels 6.1 mmol/L [110 mg/dL] or above but Ͻ7.0 mmol/L [126 mg/dL]), and normoglycemia (fasting glucose levels Ͻ6.1 mmol/L [110 mg/dL]); cigarette smoking was categorized into current (current smoker or had given up smoking Ͻ12 months before the study examination), former (positively answered to "have you ever smoked regularly before?" and had given up smoking Ն12 months before the study examination), and never smoker; alcohol intake was categorized nondrinker, Ͻonce per week, 1 to 6 days per week, 1 to 2 drinks per day, Ն3 drinks per day, and don't know/missing; and physical inactivity (yes or no) was categorized as answering negatively to "have you participated in any recreational exercise/walk in the last 2 weeks?"
Outcomes of Interest
Details of BP measurement and prevalence of hypertension in this older Australian community have been described previously. 27 Briefly, systolic and diastolic BP were recorded by trained observers from the right arm with a mercury sphygmomanometer using a cuff size appropriate for the participant's arm circumference, after he or she had been comfortably seated for Ն10 minutes. Hypertension was defined as per the Seventh Report of the Joint National Committee (JNC7) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure as systolic BP of Ն140 mm Hg, diastolic BP of Ն90 mm Hg, or a combination of self-reported hypertension diagnosis and use of antihypertensive medications. 28 (1992) (1993) (1994) . Normotensive individuals at baseline who developed hypertension according to these criteria at the 5-year follow-up examination (1997) (1998) (1999) were defined to have incident hypertension. Similar to previous studies, 29 we also examined progression by Ն1 JNC7 BP stage during the 5-year follow-up period. For this analysis, we excluded 36 individuals who were taking antihypertensive medications, because their BP level could be affected by medication use.
To examine the association between plasma fibrinogen and 5-year incident hypertension, the current study included 637 hypertensionfree individuals (286 men and 351 women) at the baseline examination from the 2334 individuals who participated in both the baseline and 5-year follow-up examination, after excluding those with missing baseline plasma fibrinogen tests (nϭ179), systolic or diastolic BP (nϭ20), and those with preexisting hypertension (nϭ1498). Similarly, we examined the cross-sectional association between plasma fibrinogen and prevalent hypertension among 3180 of the total 3654 individuals who participated in the baseline examination, after excluding missing baseline plasma fibrinogen tests (nϭ454) and systolic or diastolic BP measurements (nϭ20).
Statistical Methods
Baseline plasma fibrinogen was categorized into sex-specific tertiles (men: 1.6 to 3.2, 3.3 to 3.8, and 3.9 to 7.1 [g/L]; women: 2.2 to 3.4, 3.5 to 4.1, and 4.2 to 7.7 [g/L]) for the main analyses. Fibrinogen was also analyzed as a continuous variable (per 1 g/L increase). We performed separate analyses by gender. We used the 2 test and ANOVA to compare the relationship of selected baseline characteristics by gender. We first examined the cross-sectional association between plasma fibrinogen and prevalent hypertension and subsequently examined the prospective association between plasma fibrinogen and incident BP outcomes. We used multivariable logistic regression models to determine the odds ratio (OR) and 95% CI of prevalent hypertension (nϭ2212; first outcome of interest, crosssectional analysis), 5-year incident hypertension (nϭ361; second outcome of interest, prospective analysis), and prospective increase by Ն1 JNC7 BP stage among study participants not taking antihypertensive medications (nϭ222; third outcome of interest, prospective analysis), controlling for potential confounders. We used 2 logistic regression models: an age (years)-adjusted model and a multivariable-adjusted model, additionally adjusting for smoking (current, former, or never), alcohol intake (nondrinker, Ͻonce/week, 1 to 6 days per week, 1 to 2 drinks per day, Ն3 drinks per day, or don't know/missing), physical inactivity (yes or no), mean arterial BP (mm Hg), TC level (mmol/L), HDL-C level (mmol/L), and TG level (mmol/L); among women we additionally adjusted for menopausal status (absent or present) and ever use of hormone replacement therapy (yes or no). Logistic regression models with plasma fibrinogen tertiles as ordered categories scaled to the median for each tertile were used to assess trends in risk. To examine the consistency of the association between fibrinogen and incident hypertension, we performed analyses within subgroups of selected variables, including smoking categories (never, former, or current), BMI (Ͻ25 kg/m 2 28 We calculated the population attributable risk (Levin formula) of incident hypertension associated with a plasma fibrinogen level Ն3.9 g/L (highest tertile). SAS version 9.2 was used for all of the analyses.
Results

Baseline Characteristics
Selected baseline characteristics of the cohort subjects included in the cross-sectional analyses are presented in Table  1 . Mean age was 66 years. Women were more likely to be never smokers and nondrinkers, more likely to have higher TC and HDL-C levels and higher systolic BPs, and less likely to have diabetes mellitus and lower TG levels and circulating white blood cell counts compared with men.
Similarly, selected baseline characteristics of the cohort subjects included in the incident hypertension analysis are presented in Table 2 . Mean age was 61.7 years among men and 61.2 years among women. Women were more likely to be never smokers and nondrinkers compared with men. Men had higher BMI and were more likely to have diabetes, lower TC and HDL-C, and higher TG levels compared with women.
Among baseline subjects who participated in the follow-up examination (nϭ2334), the main reason for exclusion from the incident hypertension analysis was the presence of hypertension at the baseline examination. Compared with subjects who were included in the incident hypertension analysis (nϭ637), subjects who were not included (nϭ1697) were significantly older, more likely to consume Ն3 drinks per day, more likely to have diabetes, and more likely to be physically inactive. Table 3 presents the cross-sectional relationship between tertiles of plasma fibrinogen and prevalent hypertension at the baseline examination. Increasing tertiles of plasma fibrinogen was positively associated with prevalent hypertension both among men and women. This association was present both in the age-adjusted and the multivariable-adjusted model; corresponding models of trend were also statistically significant.
Cross-Sectional Analysis
Prospective Analysis
In Table 4 , among men, there was a clear positive association between increasing tertiles of plasma fibrinogen and 5-year incident hypertension, both in the age-adjusted and the multivariable-adjusted model. The multivariable OR (95% CI) of incident hypertension comparing men in the highest tertile (Ն3.9 g/L) with those in the lowest fibrinogen tertile (Յ3.2 g/L) was 1.95 (1.03 to 3.68). The corresponding model for assessing trend across plasma fibrinogen tertiles was also statistically significant (P trendϭ0.04). When plasma fibrinogen tertiles were analyzed as continuous variable, the multivariable OR (95% CI) of incident hypertension associated with 1 g/L increase in plasma fibrinogen was 1.47 (1.08 (Table 5) . We performed several sets of supplementary analyses. First (data not presented), we examined the association between plasma fibrinogen as a continuous variable (per 1 g/L increase) and 5-year incident hypertension and increase by Ն1 JNC7 BP stage over 5 years within subgroups of smoking categories (never, former, and current), BMI (Ͻ25 kg/m 2 and Ն25 kg/m 2 ), and JNC7 BP stages (normal BP and prehypertension). Taken together, the association between plasma fibrinogen and incident BP outcomes within these subgroups seemed to be relatively consistent, and a positive association was evident only among men but not women; however, the OR estimates failed to reach conventional levels of statistical significance (␣ϭ0.05) in some subgroups because of limitations in statistical power. Second, to examine whether the observed association between fibrinogen level and incident hypertension was explained by inflammation, we additionally adjusted for circulating white blood cell count (continuous variable) in the multivariable model in Tables 2 and 3 ; the magnitude of ORs were essentially similar. For example, among men, compared with individuals in tertile 1 of plasma fibrinogen, the multivariable OR (95% CI) of incident hypertension associated *OR (95% CI): estimated from logistic regression model adjusted for age (years). †OR (95% CI): estimated from multivariable logistic regression model additionally adjusted for smoking (current, former, or never), alcohol intake (nondrinker, Ͻonce per week, 1 to 6 days per week, 1-2 drinks per day, Ն3 drinks per day, or don't know/missing), physical inactivity (yes or no), mean arterial blood pressure (mm Hg), TC level (mmol/L), HDL-C level (mmol/L), and TG level (mmol/L).
‡JNC 7: we excluded 14 men who were taking antihypertensive medications, because their JNC 7 BP staging could be affected by the antihypertensive medication that they were consuming.
with tertiles 2 and 3 was, respectively, 1.49 (0.78 to 2.85) and 1.90 (1.00 to 3.62; P trendϭ0.047). Among men, we calculated the population-attributable risk of hypertension associated with plasma fibrinogen levels Ն3.9 g/L (highest tertile), and the population-attributable risk was 17.3%.
Discussion
In the Blue Mountains cohort of older Australians, in crosssectional analysis, we found that elevated plasma fibrinogen level was positively associated with prevalent hypertension both among men and women. In contrast, in prospective analysis, elevated plasma fibrinogen level was positively associated with 5-year incident hypertension among men but not women. This association was independent of smoking, alcohol intake, BMI, and other related factors. Among men, the OR of incident hypertension increased in a dosedependent manner with increasing plasma fibrinogen tertiles, and the association was consistently present in subgroup analyses stratified by smoking, BMI, and JNC7 BP categories. The findings from this long-term follow-up study of older, community-dwelling Australians are consistent with the recent observation reported by Folsom et al 24 suggesting a moderate positive association between plasma fibrinogen and incident hypertension among men but not among women in a middle-aged, biracial US cohort.
Our finding of an association between baseline plasma fibrinogen level and 5-year incident hypertension shows high internal validity as indicated by the independence of the association from traditional risk factors, evidence suggesting a dose-response trend in the magnitude of association, and the consistency of these findings across stratified subgroups, as well as in the magnitude of association. Consistency of the male-specific nature of this observed association between fibrinogen and incident hypertension with prospective findings from the geographically dissimilar ARIC Study 24 suggest that these findings are less likely to be because of chance. Furthermore, although several 8 -17 but not all 18 -23 previous cross-sectional epidemiological studies reported a positive association between plasma fibrinogen level and elevated BP and/or prevalent hypertension, most previous studies reporting a positive association were confined to men. 8, 11, 13, [15] [16] [17] Among women, our finding of a positive association between plasma fibrinogen and hypertension in crosssectional analysis but null association in prospective analysis is similar to the results from the ARIC Study. 24 This finding probably reflects the plasma fibrinogen elevation secondary to increase in shear stress, endothelial dysfunction, and progressive vascular disease in severe hypertension. 23, 30, 31 This possibility of reverse causality also highlights the importance of prospective analyses to clarify time sequence in any observed association between plasma fibrinogen and hypertension.
The observed lack of association between fibrinogen level and incident hypertension among women in the current study is analogous to the association between fibrinogen and other cardiovascular outcomes among women compared with men, including a weaker association with coronary heart disease 2,10 and a lack of association with carotid intima-media thickness 4 -6 and peripheral vascular disease. 7 Several plausible mechanisms could explain an observed association between elevated fibrinogen levels and hypertension, including the relation of fibrinogen to increased viscosity and peripheral vascular resistance, 20, 32 hyperinsulinemia and insulin resistance, 33, 34 and markers of inflammation. 34 -36 Gender differences in insulinemia and insulin resistance may also explain the observed lack of association among women. [37] [38] [39] In rat models, dietary lard-induced increases in BP, shown to be mediated by insulin resistance, 40 depend on the presence of testosterone. 41 Alternately, de Simone et al. 42 showed that blood viscosity tended to increase with age in men but to decrease with age and menopausal status in women. Because the majority of women in our cohort had already undergone menopause by the time of their baseline examination (Table 2 ), the differing effects on blood viscosity among men and women of increasing age during follow-up provide an alternate explanation to our findings.
The main advantages of our study include its stable general population sample base, prospective follow-up, and the use of *OR (95% CI): estimated from logistic regression model adjusted for age (years). †OR (95% CI): estimated from multivariable logistic regression model additionally adjusted for smoking (current, former, or never), alcohol intake (nondrinker, Ͻonce per week, 1 to 6 days per week, 1-2 drinks per day, Ն3 drinks per day, or don't know/missing), physical inactivity (yes or no), mean arterial blood pressure (mm Hg), TC level (mmol/L), HDL-C level (mmol/L), and TG level (mmol/L); additionally adjusted for menopausal status (absent or present) and ever use of hormone replacement therapy (yes or no) among women.
‡JNC 7: we excluded 22 women who were taking antihypertensive medications, because their JNC 7 BP staging could be affected by antihypertensive medication that they were consuming.
standardized protocols for exposure and outcome assessment. Several study limitations also need to be considered while interpreting our findings. BP levels were based on a single reading at both surveys. This could have resulted in misclassification of hypertension status (likely to be overestimation). However, previously reported hypertension prevalence, 27 incidence, 43 and trend over time 27 from our cohort are comparable to other older general population samples, though higher than in middle-aged samples. 24 Furthermore, any misclassification is likely to be nondifferential in nature and should bias the risk estimates toward a null effect. C-reactive protein, a more specific marker of inflammation, was not available to make a simultaneous comparison with fibrinogen level. Finally, it is possible that our results are biased by selective survival of the cohort. However, because fibrinogen level has been shown to be related to decreased survival, 3 selective survival is likely to underestimate our findings.
Perspectives
Findings from our study support the hypothesis of an association between elevated plasma fibrinogen level and incident hypertension among men. A corollary observation to our findings is that the recently reported BP-lowering effect of fibrates in both animal 44 -46 and human 47, 48 studies could be mediated, at least in part, by reduction in plasma fibrinogen levels. Future analyses from larger cohort studies among women are required to make conclusions regarding a lack of association among women.
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